ProfileGDS4132 / 215021_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 42% 51% 34% 39% 39% 42% 45% 34% 37% 33% 50% 49% 45% 51% 37% 39% 45% 42% 44% 47% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101108.60142
GSM201543Muscle PCOS pioglitazone 121128.9651
GSM201544Muscle PCOS pioglitazone 16187.065434
GSM201545Muscle PCOS pioglitazone 201109.42839
GSM201829Muscle PCOS pioglitazone 231107.62939
GSM201830Muscle PCOS pioglitazon 251114.3542
GSM201831Muscle PCOS pioglitazone 271119.79145
GSM201832Muscle PCOS pioglitazone 3185.957934
GSM201833Muscle PCOS pioglitazone 4188.912737
GSM201834Muscle PCOS pioglitazone 8179.641133
GSM201835Muscle PCOS after pioglitazone 102120.98850
GSM201836Muscle PCOS after pioglitazone 122120.18449
GSM201837Muscle PCOS after pioglitazone 162100.4345
GSM201838Muscle PCOS after pioglitazone 202125.48251
GSM201839Muscle PCOS after pioglitazone 23288.279637
GSM201840Muscle PCOS after pioglitazone 25296.707139
GSM201841Muscle PCOS after pioglitazone 272103.33545
GSM201842Muscle PCOS after pioglitazone 3290.599842
GSM201843Muscle PCOS after pioglitazone 42110.30344
GSM201844Muscle PCOS after pioglitazone 82120.22447